The efficacy of atomoxetine in treating adult attention deficit hyperactivity disorder (ADHD): A meta-analysis of controlled trials

详细信息    查看全文

• 作者：Vinutha Ravishankar¹ ; Suresh Vedaveni Chowdappa¹ ; Vivek Benegal ; Kesavan Muralidharan ; ^{drmuralidk@gmail.com} (Dr.)
• 关键词：ADHD ; Adult ; Atomoxetine ; Placebo ; Randomized controlled trials ; Inattention
• 刊名：Asian Journal of Psychiatry
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：24
• 期：Complete
• 页码：53-58
• 全文大小：2274 K
• 卷排序：24

文摘

Atomoxetine has signifi superior efficacy to placebo in treating adult ADHD as rated on investigator ratings of adult ADHD. The efficacy of atomoxetine is superior to placebo in treating both inattention and hyperactivity/impulsivity. Atomoxetine is significantly more efficacious in treating inattention than hyperactivity/impulsivity. Response rates could not be calculated, however most studies report about 60% response rates for 25% drop in ADHD scores.